{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "52026817",
    "licUnit": "1",
    "validDate": "2026-07-05 00:00:00.000",
    "issueDate": "2016-07-05 00:00:00.000",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202681702",
    "prodNameC": "麥欣霓膜衣錠0.5毫克",
    "prodNameE": "Mekinist Film-Coated Tablets 0.5mg",
    "indicationsName": [
        "1. 黑色素瘤: Trametinib 單一療法或與dabrafenib 併用，可用於治療罹患發生BRAF V600突變且無法切除或有轉移現象之成人性黑色素瘤( 請參閱第4.4 節和第5.1 節)。在先前接受BRAF 抑制劑療法時惡化的病人中，trametinib 單一療法並未展現出臨床活性( 請參閱第5.1 節)。\r\n2. 黑色素瘤的輔助治療: Trametinib 與dabrafenib 併用，可用於治療BRAF V600 突變且經完全切除後之第III 期黑色素瘤病人的術後輔助治療。\r\n3. 非小細胞肺癌: Dabrafenib 與trametinib 併用，可用於治療BRAF V600 突變之晚期非小細胞肺癌成人病人。\r\n4. BRAF V600E突變陽性且無法切除或轉移性實體腫瘤：Trametinib與dabrafenib併用，可用於治療BRAF V600E突變之無法切除或轉移性實體腫瘤的6歲以上兒童及成人病人，前述病人於先前治療後出現惡化現象且無任何其他適當替代治療選擇。使用限制：Trametinib不可用於治療結腸直腸癌病人，因為這類病人已知對BRAF抑制作用具先天抗藥性。"
    ],
    "does": "1116",
    "packageUnit": [
        {
            "packageSpec": "2~1000錠以下",
            "packageUnit": "A3"
        }
    ],
    "medMCode": "06",
    "maMedCode": "",
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "E79A7143-3FC8-4D1D-BE17-4FBCEC25F18B",
    "subCategory": [],
    "ingredientsDesc": [
        "Trametinib Dimethyl Sulfoxide"
    ],
    "restraintItemsCode": [
        "02",
        "07",
        "5F"
    ],
    "applicantName": "台灣諾華股份有限公司",
    "applicantAddr": "台北市中山區民生東路三段2號8樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2021-07-05",
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "NOVARTIS PHARMA STEIN AG",
            "factoryAddr": "SCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLAND",
            "factoryCompanyAddr": "CH-4002,BASEL,SWITZERLAND",
            "countryCode": "CH",
            "processCode": [
                {
                    "value": "3O",
                    "name": "製造(不含包裝)"
                }
            ],
            "processCodeStr": "3O;製造(不含包裝)",
            "factoryKind": "M",
            "factoryNo": "FCH0088000",
            "factoryInfo": null,
            "qsd": null,
            "factoryMadeIn": null
        },
        {
            "factoryCode": "2",
            "factoryName": "Novartis Pharmaceutical Manufacturing LLC",
            "factoryAddr": "Verovskova ulica 57 1000 Ljubljana Slovenia",
            "factoryCompanyAddr": "",
            "countryCode": "SI",
            "processCode": [
                {
                    "value": "16",
                    "name": "包裝及分裝"
                }
            ],
            "processCodeStr": "16;包裝及分裝",
            "factoryKind": "M",
            "factoryNo": "FSI0008000",
            "factoryInfo": null,
            "qsd": null,
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013005710",
            "ingredientsName": "Trametinib Dimethyl Sulfoxide",
            "ingredientsDesc": "Trametinib Dimethyl Sulfoxide",
            "concentDesc": "(equivalent to Trametinib......0.50 mg)",
            "concent": "0.5640",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EE01"
        }
    ],
    "licBaseId": "A7AEEC99-34B6-4582-AE68-A55FD14056F7"
}